CymitQuimica logo
Angiogenesi

Angiogenesi

Gli inibitori dell'angiogenesi sono composti che interferiscono con la formazione di nuovi vasi sanguigni, un processo cruciale nella crescita e metastasi del cancro. Inibendo l'angiogenesi, questi composti possono limitare l'apporto di sangue ai tumori, rallentandone o arrestando la crescita. Gli inibitori dell'angiogenesi sono fondamentali nella ricerca sul cancro e nello sviluppo terapeutico, offrendo approfondimenti sui meccanismi di progressione tumorale e potenziali trattamenti per il cancro e altre malattie legate all'angiogenesi. Presso CymitQuimica, offriamo un'ampia gamma di inibitori dell'angiogenesi di alta qualità per supportare le tue ricerche in oncologia e biologia vascolare.

Sottocategorie di "Angiogenesi"

Mostrare 6 più sottocategorie

Trovati 2121 prodotti di "Angiogenesi"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • Anticancer agent 133


    Compound Rh2 (Anticancer agent 133) is a cytotoxic and antimetastatic agent that induces cell cycle arrest, apoptosis, and autophagy.
    Formula:C24H19Cl3N5ORh
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:602.71
  • Conbercept

    CAS:
    Conbercept (KH902) is a fusion protein comprising the second immunoglobulin C-like domain of FLT1 and the third and fourth immunoglobulin C-like domains of KDR
    Purezza:98%
    Colore e forma:Liquid
  • Lyn peptide inhibitor

    CAS:
    Inhibits Lyn kinase, blocks IL-5 receptor, prevents eosinophil differentiation and reduces asthma-related inflammation in mice.
    Formula:C115H184N30O24
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:2370.91
  • SIAIS100


    SIAIS100, a potent BCR-ABL PROTAC degrader, demonstrates a DC50 value of 2.7 nM, highlighting its efficacy.
    Formula:C44H50ClF2N9O5S
    Colore e forma:Solid
    Peso molecolare:890.44
  • JAK 3 inhibitor IV

    CAS:
    JAK 3 inhibitor IV (ZM 39923 hydrochloride) is a JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to
    Formula:C16H19NO
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:241.33
  • AT-533

    CAS:
    AT-533 inhibits Hsp90, HSV, hinders HIF-1α/VEGF/VEGFR-2, Erk1/2, FAK, Akt/mTOR/p70S6K, and blocks tumor growth, angiogenesis, and HUVEC activities.
    Formula:C23H30N4O3
    Purezza:99.67%
    Colore e forma:Soild
    Peso molecolare:410.51
  • VEGFR-2-IN-36


    VEGFR-2-IN-36 (compound 15) serves as a potent VEGFR-2 inhibitor, exhibiting an IC50 value of 0.067 μM, and acts as an apoptosis inducer with demonstrated
    Formula:C24H23N7O5
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:489.48
  • SNIPER(ABL)-039

    CAS:
    SNIPER(ABL)-039, conjugating Dasatinib (ABL inhibitor) to LCL161 derivative (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of
    Formula:C54H68ClN11O9S2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:1114.77
  • Tephrosin

    CAS:
    Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities.
    Formula:C23H22O7
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:410.42
  • Tyrosinase-IN-16

    CAS:
    Tyrosinase-IN-16 inhibited tyrosinase.
    Formula:C8H6BrN3S
    Purezza:99.94%
    Colore e forma:Solid
    Peso molecolare:256.12
  • Bevasiranib

    CAS:
    Bevasiranib is a siRNA targeting VEGF production, key in choroidal neo-vascularization and wet AMD.
    Colore e forma:Solid
  • Wu-5

    CAS:
    Wu-5 is a potent USP10 inhibitor that inhibits FLT3 and AMPK pathways, promoting the breakdown of FLT3-ITD and inducing apoptosis.
    Formula:C15H13NO7S
    Purezza:99.65%
    Colore e forma:Soild
    Peso molecolare:351.33
  • Varlitinib

    CAS:
    Varlitinib (ASLAN001) is a potent, reversible, small molecule pan-EGFR inhibitor with IC50s of 7, 2, 4 nM for HER1, HER2 and HER4, respectively.
    Formula:C22H19ClN6O2S
    Purezza:99.7%
    Colore e forma:Solid
    Peso molecolare:466.94
  • Laprituximab

    CAS:
    Laprituximab (J2898A) is a humanized anti-EGFR antibody used for synthesizing ADC compound Laprituximab emtansine.
    Purezza:>95%
    Colore e forma:Liquid
  • SJ10542

    CAS:
    SJ10542: potent JAK2/3-targeting PG-PROTAC; DC50s: JAK2 - 14 nM, JAK3 - 11 nM, JAK2-fusion ALL - 24 nM; CRBN recruiter.
    Formula:C41H46N12O5S
    Colore e forma:Solid
    Peso molecolare:818.95
  • BCR-ABL-IN-3

    CAS:
    BCR-ABL-IN-3 irreversibly inhibits Bcr-Abl with <100 nM IC50, showing significant anti-cancer effects.
    Formula:C20H17ClF2N4O3S
    Colore e forma:Solid
    Peso molecolare:466.89
  • SC209

    CAS:
    SC209, a STRO-002 metabolite from patent WO2021247798, synthesizes anti-EGFR ADCs.
    Formula:C27H44N4O4
    Colore e forma:Solid
    Peso molecolare:488.66
  • SJF 1521

    CAS:
    SJF 1521 is an EGFR degrader belonging to the PROTAC class that selectively degrades EGFR while preserving HER2.
    Formula:C57H61ClFN7O9S
    Purezza:99.20%
    Colore e forma:Solid
    Peso molecolare:1074.65
  • Coprelotamab

    CAS:
    <p>Coprelotamab (GB-221) is an IgG-κ monoclonal antibody that targets EGFR2, frequently produced in CHO DG44 (Chinese Hamster Ovary) cells [1].</p>
    Purezza:98%
    Colore e forma:Liquid
  • Dacomitinib metabolite M2

    CAS:
    Dacomitinib metabolite M2 is also known as Dacomitinib cysteine conjugate. Dacomitinib inhibits both the wild-type (WT) EGFR and EGFR T790M.
    Formula:C27H32ClFN6O4S
    Colore e forma:Solid
    Peso molecolare:591.1